Quantum Technology - China has established the world's largest quantum communication network, comprising 8 core sites and 159 access stations [4] - The third-generation superconducting quantum computer "Benyuan Wukong" is set to officially operate in January 2024, with over 80% domestic components [9] - "Benyuan Wukong" has been accessed over 37 million times by users from 163 countries, completing 740,000 quantum computing tasks across various fields [11] Biological Manufacturing - Biological manufacturing combines traditional fermentation and synthetic biology, opening new industrial spaces [12] - China holds over 70% of global biological fermentation capacity, leading in the production of amino acids and organic acids [12] - Challenges include the need for core strains and key enzymes, as well as the development of a robust biological information database [13] Nuclear Fusion Energy - Controlled nuclear fusion, known as "artificial sun," is advancing with significant breakthroughs in technology [14][15] - The "China Circulation No. 3" has achieved record ion and electron temperatures of 120 million and 160 million degrees Celsius, respectively [15] - By 2027, "China Circulation No. 3" is expected to conduct burning plasma experiments, moving towards commercial fusion power generation by mid-century [15] Brain-Computer Interface - Brain-computer interface technology is expanding into various fields, including medical rehabilitation and consumer electronics [17][18] - The industry is supported by a collaborative ecosystem involving research, industry, and policy frameworks [18] - Key focus areas include core technology development, innovation ecosystem enhancement, and ethical regulatory frameworks [18] Humanoid Robotics - Humanoid robots are evolving rapidly, with advancements in joint modules and motion control [19][20] - The Shenzhen area is developing a "embodied intelligence port," fostering a complete industrial chain from R&D to application [20] - The local government has introduced action plans to promote technological innovation and industry development in humanoid robotics [20] 6G Technology - 6G technology aims to enhance connectivity and integrate various technologies, supporting the development of a smart society [21][22] - It is expected to achieve 10 to 100 times the speed and reliability of 5G, covering all domains of connectivity [21] - China is advancing in 6G research and aims for commercial implementation by 2030 [22]

Core Insights - The article highlights the growing importance of biomanufacturing in China's economic strategy, positioning it alongside quantum technology and embodied intelligence as a key future industry [1] - The shift from a generics-based pharmaceutical industry to one focused on innovative drug development has garnered significant global attention [1] Industry Overview - Biomanufacturing is recognized for its potential to revolutionize various sectors, including healthcare and agriculture, with examples such as rice-derived human serum albumin and gene editing technologies [2] - The application of biomanufacturing extends to environmental solutions, such as biodegradable plastics and the production of hyaluronic acid using microorganisms [2] Health and Longevity - China's average life expectancy is projected to reach 79 years by 2024, reflecting advancements in healthcare, though challenges remain in managing diseases like Alzheimer's [3] - A shift in medical focus from treatment to prevention and health maintenance is emphasized, with early disease detection being crucial for improving life quality and reducing healthcare costs [4][5] Global Positioning - China is recognized as a leading player in the biotechnological field, competing closely with the US, and is noted for its cost-effective innovations in drug development [6][7] - The disparity in drug pricing between China and the US is highlighted, with Chinese drugs being significantly more affordable, enhancing accessibility [6] Future Prospects - The article discusses the potential for China's biomanufacturing sector to expand internationally, emphasizing the importance of addressing global health needs rather than solely focusing on high-profit markets [8] - The upcoming implementation of new regulations is expected to bolster the biopharmaceutical industry, positioning China as a global center for biotherapy [10] Areas of Growth - Four key areas for significant advancements in biomanufacturing are identified: biomedicine and high-end medical devices, agricultural biotechnology, bioplastics, and marine biomanufacturing [11][12]

Core Insights - The article emphasizes the growing importance of biomanufacturing in China's economic development, highlighting its recognition alongside quantum technology and embodied intelligence as a key future industry [1] - The shift from a generics-based pharmaceutical industry to one focused on innovative drugs has garnered significant global attention [1] Industry Position - Biomanufacturing is positioned as a miraculous field with transformative potential, exemplified by companies like He Yuan Biotechnology, which utilizes rice to produce human serum albumin, addressing China's reliance on imports [2] - Gene editing technologies are revolutionizing the treatment of infectious and genetic diseases, showcasing the power of biomanufacturing to alter production and lifestyle [2] Health and Longevity - China's average life expectancy is projected to reach 79 years by 2024, necessitating a focus on preventing diseases to improve quality of life and reduce economic burdens [3] - The medical community is shifting towards a health-centered approach, emphasizing the need to manage diseases like Alzheimer's to extend life expectancy further [3] Technological Advancements - The potential for nationwide genetic testing could significantly enhance disease prevention, particularly for age-related conditions, by making screenings more affordable and accessible [4][5] - The U.S. acknowledges China's rapid rise in biotechnology, with both countries being leaders in the field, particularly in terms of application and industrial transformation [6] Competitive Landscape - The article discusses the comparable capabilities of China and the U.S. in biomanufacturing, noting that both utilize similar foundational tools, which allows for competitive parity [7] - China's biopharmaceutical sector is characterized by a strong engineering workforce and a culture of resilience in competition, contributing to its rapid advancements [7] Global Market Opportunities - Despite potential challenges from U.S. policies, China is encouraged to explore markets in developing regions, emphasizing the importance of technology accessibility for broader populations [8] - The trend of Chinese pharmaceutical companies engaging in international business development and licensing is expected to double, indicating a robust global strategy [9] Future Directions - Significant advancements are anticipated in four key areas: biomedicine and high-end medical devices, agricultural biotechnology, bioplastics, and marine biomanufacturing [10] - The agricultural sector is expected to benefit from improved breeding technologies and sustainable practices, while marine resources are seen as a new frontier for biomanufacturing [10]

Core Insights - The article discusses the development of future industries in China, focusing on quantum technology, biomanufacturing, nuclear fusion energy, brain-computer interfaces, and embodied intelligence as key growth areas for high-quality development [10][15][18]. Quantum Technology - The "Quantum Avenue" in Hefei is home to numerous tech companies, creating a complete ecosystem for quantum computing, communication, and measurement [11]. - The third-generation superconducting quantum computer "Benyuan Wukong" is set to officially operate in January 2024, with over 80% of its components domestically produced [11]. - "Benyuan Wukong" has been accessed over 37 million times by users from 163 countries, completing 740,000 quantum computing tasks across various fields [12]. Biomanufacturing - Biomanufacturing combines traditional fermentation and synthetic biology, enabling customized production of medical products and sustainable materials [13]. - China holds a significant advantage in biomanufacturing, accounting for over 70% of global fermentation capacity and leading in the production of amino acids and organic acids [13]. - Challenges include the need for core strains and key enzymes, which require improved biological information databases and design tools [14]. Nuclear Fusion Energy - China is making significant strides in nuclear fusion research, with the "China Circulation No. 3" achieving record temperatures of 120 million degrees Celsius for ions and 160 million degrees Celsius for electrons [16]. - The establishment of the first International Atomic Energy Agency fusion research and training center in China marks a shift from participant to key player in global fusion energy development [16]. Brain-Computer Interfaces - Brain-computer interface technology is rapidly expanding into various fields, particularly in healthcare for rehabilitation and assistive technologies [18]. - China is developing a robust ecosystem for brain-computer interfaces, with significant advancements in clinical applications and policy support aimed at creating a competitive industry by 2030 [19]. Embodied Intelligence - The development of humanoid robots is advancing, with companies focusing on high-performance hardware and software to enhance capabilities in various applications [20]. - Shenzhen is emerging as a hub for embodied intelligence, with a complete industrial chain supporting technology development and market application [21]. 6G Technology - 6G technology aims to integrate communication, sensing, advanced computing, and AI, significantly enhancing connectivity and supporting the digital transformation of society and industries [22]. - China is leading in 6G research and is expected to achieve commercial deployment by 2030, with ongoing efforts in technology validation and ecosystem development [23].

Core Insights - China is a key trade partner for Argentina, with significant opportunities arising from this relationship [1] Trade Relations - China is Argentina's second-largest trading partner, importing key products such as soybeans and beef [1] - The emphasis on technological independence and food security in China presents opportunities for Argentina, a major global food producer [1] Technological Advancements - China's advancements in artificial intelligence are notable, with examples including efficient management of container cranes and automated production lines [1] - The "14th Five-Year Plan" in China highlights key areas of focus such as quantum technology, biomanufacturing, and sixth-generation mobile communications [1] Market Dynamics - Argentine visitors to China observe that Chinese products are of high quality and competitively priced, with excellent customer service [1] - The rapid delivery of customized products, such as tailored suits within 24 hours, reflects the efficiency of Chinese businesses [1]

Core Insights - China is a key trade partner for Argentina, with significant opportunities arising from this relationship [1] Trade Relations - China is Argentina's second-largest trading partner, importing key products such as soybeans and beef [1] - The focus on technological independence and food security in China presents opportunities for Argentina, a major global food producer [1] Technological Advancements - China's advancements in artificial intelligence are notable, with applications in logistics and manufacturing, enhancing operational efficiency [1] - The "14th Five-Year Plan" in China emphasizes key areas such as quantum technology, biomanufacturing, and sixth-generation mobile communications [1] Market Dynamics - Argentine visitors to China observe that Chinese products are of high quality and competitively priced, with excellent customer service [1] - The rapid delivery services in China, such as custom suits delivered within 24 hours, highlight the efficiency of Chinese businesses [1]

Group 1 - The article emphasizes the strategic importance of biological manufacturing as a key industry for future development, highlighted by its inclusion in the 15th Five-Year Plan alongside quantum technology and 6G [2] - The upcoming "SynBio China Fourth Synthetic Biology and Biomanufacturing Conference" will take place in Shenzhen on January 8-9, 2026, focusing on industrialization technology challenges and providing comprehensive solutions for intelligent manufacturing and green production [3][2] - The conference aims to gather experts from academia and industry to analyze the entire process of "design-build-test-learn" in synthetic biology, addressing the optimization and innovation opportunities in various industrialization stages [2] Group 2 - The conference is expected to host around 1,000 participants, indicating significant interest and engagement in the field of synthetic biology and biomanufacturing [3] - There are opportunities for exhibitors from synthetic biology and modern biotechnology sectors to showcase their products and technologies at the conference [9] - Registration for the conference is currently free but limited, emphasizing the need for early registration to secure participation [12]

Core Viewpoint - The article emphasizes the rising importance of biomanufacturing as a strategic and innovative field that disrupts traditional production methods, presenting it as a new growth point for optimizing industrial structure and transforming economic models. The release of the "2025 China Synthetic Biomanufacturing Industry Development White Paper" highlights the current state, trends, and challenges of the biomanufacturing industry in China [1]. Group 1: Current State and Trends - The white paper outlines the development status and trends of biomanufacturing, analyzing the global landscape and key platform facilities [5]. - It compares the biomanufacturing sectors of China and the United States, identifying competitive advantages and areas for improvement [5]. - Future development trends in biomanufacturing are discussed, indicating a shift towards more integrated and sustainable practices [5]. Group 2: Policy Landscape - The report details major policies affecting biomanufacturing in both domestic and international contexts, providing insights into regulatory frameworks that shape the industry [5]. - It highlights the importance of supportive policies for fostering innovation and growth in the biomanufacturing sector [5]. Group 3: Industry Map and Applications - The white paper presents a comprehensive map of the Chinese biomanufacturing industry, identifying key players and their roles [5]. - It analyzes the biomanufacturing industry chain and key application areas, including pharmaceuticals, food, personal care, agriculture, chemicals, materials, and energy [5]. Group 4: Key Enterprises and Investment Landscape - The report identifies ten leading enterprises in the Chinese biomanufacturing sector, showcasing their contributions and market positions [6]. - It summarizes the strategic directions of 15 listed companies in synthetic biology, highlighting their investment and development strategies [6]. - The investment landscape for synthetic biology in China is examined, providing data on funding trends and opportunities [6]. Group 5: Challenges and Recommendations - The white paper discusses the challenges faced by the biomanufacturing industry in China, including technological, regulatory, and market barriers [6]. - It offers targeted policy recommendations to address these challenges and promote sustainable growth in the biomanufacturing sector [6].

Core Insights - The article highlights the significant transformation in the industrial sector driven by biotechnology, emphasizing its role in achieving sustainable growth and meeting carbon neutrality goals [1][2][3] - The Chinese government has officially included biomanufacturing in its national strategy, indicating a strong commitment to advancing this sector through unprecedented measures and a national framework [1][10] - The biomanufacturing industry is projected to capture one-third of the global manufacturing output by the end of the century, creating a market worth approximately $30 trillion [4] Industry Overview - Biomanufacturing is transitioning traditional industries from high-energy, high-emission chemical processes to low-energy, low-pollution biological processes, which is essential for sustainable development [2][12] - The industry is gaining momentum globally due to its economic advantages, mild reaction conditions, and renewable raw materials, leading to a new industrial revolution [3] Government Initiatives - The Ministry of Industry and Information Technology (MIIT) has initiated the selection of "biomanufacturing landmark products" and "biomanufacturing pilot platforms," reflecting the strategic intent to identify and cultivate leading industry examples [5][10] - The MIIT's focus on key areas such as biomanufacturing, integrated circuits, and advanced materials aims to achieve decisive breakthroughs in core technologies [13] Company Spotlight: Jia Bi You - Jia Bi You has emerged as a focal point in the industry, successfully developing 2'-fucosyllactose (2'-FL), a human milk oligosaccharide with significant immune-regulating properties, which has been recognized as a landmark product by the MIIT [7][10] - The company has also been included in the first batch of biomanufacturing pilot capacity construction platforms and high-performance bioreactor innovation tasks, showcasing its advanced technology and market potential [8][9] Technological Advancements - Jia Bi You integrates artificial intelligence with synthetic biology to create an intelligent research and development platform, enhancing its capabilities in enzyme design and microbial strain development [18][37] - The company has developed a comprehensive biomanufacturing platform that includes advanced fermentation systems and real-time monitoring technologies, significantly improving production efficiency and product quality [18][21] Market Position and Growth - Jia Bi You has established itself as a leader in the biomanufacturing sector, with a diverse product portfolio that includes ARA, DHA, and various high-value nutrients, positioning itself to capture significant market opportunities [27][36] - The company has successfully penetrated international markets, collaborating with major global players and obtaining necessary certifications for its products, thereby expanding its global footprint [41][42] Future Prospects - The biomanufacturing sector is expected to experience rapid growth, driven by government support and technological innovation, with Jia Bi You poised to play a pivotal role in this transformation [45][46] - The establishment of innovation centers and collaborative initiatives in regions like Hubei is expected to enhance the overall competitiveness of the biomanufacturing industry in China [29][34]

本报讯 （记者冯思婕）近日，工业和信息化部、国家发展改革委联合公示全国首批生物制造中试能力建设平台名单，全国 共有43家单位入选。由传化集团有限公司（以下简称"传化集团"）与国有资本合作建设运营的"杭州合成生物产业中试（验 证）中心"成功入选，成为浙江省代表性平台之一。这标志着传化集团在合成生物产业领域的技术实力与产业化能力获得国家 级权威认可。 名单公示/官网截图 | 中华人民共和国工业和信息化部 | ry and Information Technology of the People's Republic of China | | | | ● 阳光小信 无障碍 手机端 邮箱 请输入关键字 | | --- | --- | --- | --- | --- | --- | | (2 | 首页 组织机构 | 新闻发布 | 政务公开 | 政务服务 | 互动交流 T1 | | 首页 > 工业和信息化部 > 机关司局 > 消费品工业司 > 食品 | | | 4-1660 4:1 ) 446 -- 1 | | | | 序号 | 所在单位名称 | 主要服务领域 | 地址 | 联系电话 | 电子邮箱 | 用 | | --- ...